GYN cancers

DCI oncologists — doctors Davidson, Kamal, Moss, Secord, Menendez, and Kelley — blaze a trail, at the national level, in breast & gynecologic cancers.

The Division of Gynecologic Oncology, Duke Department of OB-GYN commemorates 50 years of innovation and care.

In October, the DCI Office of Health Equity & the Mexican Consulate in Raleigh brought awareness to breast, uterine, and cervical cancer detection and prevention.

Haley Moss, MD, MBA, will work to expand access to care for women veterans through teleoncology and clinical trials in new role at the U.S. Dept. of Veterans Affairs.

A project led by Brittany Davidson, MD, is one of 10 selected for funding this year by the Duke Institute for Health Innovation.

Ready, set, register for the Virtual Gail Parkins Memorial Ovarian Cancer Walk & 5K Run. Educational Symposium (9.26) features doctors Berchuck and Secord.

Radiation oncologist Junzo Chino, MD, served as vice chair of the task force releasing recommendations for radiation therapy in nonmetastatic cervical cancer.

If mothers, sisters and daughters have a history of breast and ovarian cancers, a man's risk for prostate cancer is also significantly increased.

Updated genetic screening guidelines published by NCCN feature emerging evidence on personalized medicine.

The fundraiser, which supports Duke research, has been held each year since 2002 in memory of  Gail Parkins. The annual event saw its biggest ever turnout of survivors.

After a routine exam in February 2018, Leigh Zagorski, 32, learned that her preliminary pap smear results indicated abnormal cells. What was next?

Women with gynecological cancer have more treatment options than ever. Currently, Duke has 15 clinical trials open for women with gynecologic cancers.